CLASSIF1 Classification

• < AML    < fig.4

fig.5: Prognostic Disease Classification Masks

- Prognostic data patterns were obtained during therapeutic risk stratification of the same patients by immunophenotype, cytogenetic and clinical parameters (L1).
- Prognostic and predictive data patterns show only partial similarity (CD4, CD11b, CD13, HLA-DR)

Literature References:
L1. Repp R, Schaekel U, Helm G, Thiede C, Soucek S, Pascheberg U, Wandt H, Aulitzky W, Bodenstein H, Kuse R, Link H, Ehninger G, Gramatzki M and AML-SHG Study Ehninger G, Gramatzki M and SHG-AML study group Immunophenotyping is an independent factor for risk stratification in AML. Cytometry 53B:11-19, (2003) (PDF)

• < AML    < fig.4